Serum vaspin levels in type 2 diabetic women in relation to microvascular complications

European Journal of Endocrinology

Volumn 160, Issue 1, 2009, Pages 65-70

  Gulcelik, Nese Ersoz ^a   Karakaya, Jale ^a   Gedik, Arzu ^a   Usman, Aydam ^a   Gurlek, Alper ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN; METFORMIN; SERINE PROTEINASE INHIBITOR; UNCLASSIFIED DRUG; VISCERAL ADIPOSE TISSUE DERIVED SERINE PROTEASE INHIBITOR; CHOLESTEROL; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN; SERPINA12 PROTEIN, HUMAN; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC MICROANGIOPATHY; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HOMEOSTASIS; HUMAN; INSULIN BLOOD LEVEL; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; BLOOD; DIABETIC ANGIOPATHY; METABOLISM; MIDDLE AGED; STATISTICAL MODEL;

BLOOD GLUCOSE; CHOLESTEROL; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DIABETIC NEPHROPATHIES; DIABETIC NEUROPATHIES; DIABETIC RETINOPATHY; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN; LINEAR MODELS; MIDDLE AGED; SERPINS; TRIGLYCERIDES;

EID: 58249092970     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-08-0723     Document Type: Article

References (19)

1. Kaplan NM. The deadly quartet. Upper body obesity, glucose intolerance, hypertriglyceridemia and hypertension. Archives of Internal Medicine 1989 149 1514-1520.
2. Frayn KN. Visceral fat and insulin resistance - causative or correlative? British Journal of Nutrition 2000 83 S71-S77.
3. Wajchenberg BL. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocrine Reviews 2000 21 697-738.
4. Björntorp P. Metabolic implication of body fat distribution. Diabetes Care 1991 14 1132-1143.
5. Van Harmelen V, Reynisdottir S, Eriksson P, Thorne A, Hoffstedt J, Lonnqvist F & Arner P. Leptin secretion from subcutaneous and visceral adipose tissue in women. Diabetes 1998 47 913-917.
6. Klöting N, Graham TE, Berndt J, Kralisch S, Kovacs P, Wason CJ, Fasshauer M, Schön MR, Stumvoll M, Blüher M & Kahn BB. Serum retinol-binding protein is more highly expressed in visceral than in subcutaneous adipose tissue and is a marker of intra-abdominal fat mass. Cell Metabolism 2007 6 79-87.
7. Alessi MC, Peiretti F, Morange P, Henry M, Nalbone G & Juhan-Vague I. Production of plasminogen activator inhibitor 1 by human adipose tissue: possible link between visceral fat accumulation and vascular disease. Diabetes 1997 46 860-867.
8. Fried SK, Bunkin DA & Greenberg AS. Omental and subcutaneous adipose tissue of obese subjects release interleukin 6: depot difference and regulation by glucocorticoid. Journal of Clinical Endocrinology and Metabolism 1998 83 847-850.
9. Hida K, Wada J, Eguchi J, Zhang H, Baba M, Seida A, Hashimoto I, Okada T, Yasuhara A, Nakatsuka A, Shikata K, Hourai S, Futami J, Watanabe E, Matsuki Y, Hiramatsu R, Akagi S, Makino H & Kanwar YS. Visceral adipose tissue-derived serine protease inhibitor: a unique insulin-sensitizing adipocytokine in obesity. PNAS 2005 102 10610-10615.
10. Wada J. Vaspin: a novel serpin with insulin-sensitizing effects. Expert Opinion on Investigational Drugs 2008 17 327-333.
11. Klöting N, Berndt J, Kralisch S, Kovacs P, Fasshauer M, Schon MR, Stumvoll M & Blüher M. Vaspin gene expression in human adipose tissue: association with obesity and type 2 diabetes. Biochemical and Biophysical Research Communications 2006 339 430-436.
12. Seeger J, Ziegelmeier M, Bachman A, Lössner U, Kratzch J, Blüher M, Stumvoll M & Fasshauer M. Serum levels of the adipokine vaspin in relation to metabolic and renal parameters. Journal of Clinical Endocrinology and Metabolism 2008 93 247-251.
13. Youn BS, Klöting N, Kratzsch J, Lee N, Park JW, Song ES, Ruschke K, Oberbach A, Fasshauer M, Stumvoll M & Blüher M. Serum vaspin concentrations in human obesity and type 2 diabetes. Diabetes 2008 57 372-377.
14. Li Q, Chen R, Moriya J, Yamakawa J, Sumino H, Kanda T & Takahashi T. A novel adipocytokine, visceral adipose tissue-derived serine protease inhibitor (vaspin) and obesity. Journal of International Medical Research 2008 36 625-629.
15. Tan BK, Heutling D, Chen J, Farhatullah S, Adya R, Keay SD, Kennedy CR, Lehnert H & Randeva HS. Metformin decreases the adipokine vaspin in overweight women with polycystic ovary syndrome concomitant with improvement in insulin sensitivity and a decrease in insulin resistance. Diabetes 2008 57 1501-1507.
16. Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, Hadden D, Turner RC & Holman RR. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000 321 405-412.
17. DCCT. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. New England Journal of Medicine 1993 329 977-986.
18. The ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. New England Journal of Medicine 2008 358 2560-2572.
19. American Diabetes Association. Standards of medical care in diabetes - 2008. Diabetes Care 2008 31 S12-S54.